Table 1.
Baseline Characteristics of Kawasaki Disease Trial Subjects by IVIG Retreatment Status. Mean±SD (median) or % unless otherwise specified.
| Variable | N | IVIG Retreated | N | Not IVIG- Retreated  | 
p-value* | 
|---|---|---|---|---|---|
| Age, years | 27 | 3.7±2.5 (3.3) | 171 | 3.2±2.2 (2.8) | .30 | 
| Age ≤ 1 year | 27 | 7% | 171 | 18% | .26 | 
| Age < 6 months | 27 | 4% | 171 | 5% | 1.00 | 
| Male | 27 | 82% | 171 | 60% | .033 | 
| Hispanic | 25 | 20% | 165 | 18% | .78 | 
| Race | 27 | 171 | .51 | ||
| White | 48% | 102 | 60% | ||
| Black | 26% | 30 | 18% | ||
| Asian | 19% | 22 | 13% | ||
| Other/Mixed/Unknown | 7% | 17 | 10% | ||
| Fever Days prior to Diagnosis | 27 | 6.3±1.6 (6.0) | 171 | 6.6±1.5 (6.0) | .34* | 
| Fever Days ≤ 4 | 27 | 7% | 171 | 6% | .67 | 
| Assigned to Steroids | 27 | 44% | 171 | 52% | .54 | 
| Received Steroids | 27 | 41% | 171 | 52% | .41 | 
| Baseline Echo Z-Scores | |||||
| Proximal RCA | 24 | 1.2±1.3 (0.9) | 166 | 1.2±1.4 (1.0) | .96* | 
| Proximal LAD | 26 | 1.3±1.7 (1.1) | 167 | 1.1±1.5 (1.0) | .58* | 
| Max Z (pRCA, pLAD) | 26 | 1.8±1.7 (1.5) | 169 | 1.6±1.5 (1.4) | .69* | 
| Left Main | 26 | 1.1±1.0 (1.1) | 168 | 0.9±1.1 (0.7) | .29* | 
| Baseline Laboratory Values | |||||
| C-Reactive Protein, mg/dL | 22 | 12.9±8.3 (14.3) | 116 | 9.2±8.0 (6.8) | .06 | 
| C-Reactive Protein ≥ 10 mg/dL | 22 | 59% | 116 | 33% | .03 | 
| ESR, mm/hr | 25 | 63±34 | 162 | 68±32 | .48* | 
| White blood cell count, 103/mm3 | 27 | 12.9±5.0 | 171 | 14.0±5.5 | .30 | 
| % Neutrophils | 26 | 60±25 (66) | 171 | 55±21 (59) | .13 | 
| Neutrophils ≥ 80% | 26 | 23% | 171 | 8% | .03 | 
| Hematocrit, % | 27 | 31±5 | 171 | 32±3 | .18* | 
| Hemoglobin, g/dL | 27 | 10.6±1.5 | 171 | 11.0±2.2 | .10* | 
| Platelets × 104/mm3 | 27 | 34.1±9.0 (32.9) | 171 | 40.2±14.7 (39.4) | .005* | 
| Plaletets ≤ 30 × 104/mm3 | 27 | 33% | 171 | 23% | .34 | 
| Albumin, g/dL | 27 | 2.9±0.6 | 155 | 3.4±0.6 | .0003* | 
| IgG, median | 25 | 714 | 138 | 687 | .54 | 
| IgA, median | 25 | 92 | 133 | 82 | .98 | 
| IgM, median | 25 | 97 | 132 | 110 | .65 | 
| ALT, IU/L, median | 20 | 70.0 | 144 | 28.5 | .06 | 
| AST, IU/L, median | 20 | 39.0 | 128 | 34.0 | .40 | 
| AST ≥ 100 IU/L | 20 | 10% | 128 | 10% | 1.0 | 
| Sodium, mmol/L | 19 | 135±2 | 124 | 136±3 | .28 | 
| Sodium < 133 mmol/L | 19 | 16% | 124 | 13% | .72 | 
| Total bilirubin, mg/dL, median | 17 | 0.9 | 100 | 0.3 | .12 | 
| Total bilirubin ≥ 0.9 mg/dL | 17 | 53% | 100 | 21% | .01 | 
p-value for proportions from exact test; p-value for continuous variables from Wilcoxon rank sum test except where noted with an asterisk to indicate t-test N represents the total available sample size for the variable in each group.
IVIG= Intravenous immunoglobulin
RCA= Right coronary artery
LAD= Left anterior descending coronary artery
pRCA= Proximal RCA
pLAD= Proximal LAD
ESR= Erythrocyte sedimentation rate
IgG=Immunoglobulin G
IgA=Immunoglobulin A
IgM=Immunoglobulin M
ALT=Alanine aminotransferase
AST=Aspartate aminotransferase